Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Potential Role for Oridonin in Cancer Control: Mechanisms of Autophagy and Apoptosis Publisher Pubmed



Arefnezhad R1, 6 ; Rahimishatranlo S7 ; Rabiei B8 ; Zarei H9 ; Nazari A10 ; Goleij P11, 12 ; Mahmoudpour F13 ; Khalafi N1 ; Hajighasemi M2 ; Farkhondeh T3 ; Samini M4 ; Samarghandian S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Coenzyme R Research Institute, Department of basic medicine sciences, Tehran, Iran
  2. 2. Department of basic medicine sciences, Faculty of Biotechnology, Amol University of Special Modern Technologies, Amol, Iran
  3. 3. School of Pharmacy, Department of Basic, Birjand University of Medical Sciences, Iran
  4. 4. Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Department of Physiology, Faculty of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Iran
  6. 6. Student Research Committee, Shiraz University of Medical Sciences, Department of medicine, Shiraz, Iran
  7. 7. Young Researchers and Elite Club, Faculty of Medicine, Department of basic medicine sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  8. 8. Department of basic medicine sciences, Faculty of Pharmacy, Shahid Beheshti University, Tehran, Iran
  9. 9. Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  10. 10. School of Medicine, Department of basic medicine sciences, Tehran University of Medical Sciences, Tehran, Iran
  11. 11. Department of basic medicine sciences, Faculty of Biology, Sana Institute of Higher Education, Sari, Iran
  12. 12. PhytoPharmacology Interest Group [PPIG], Universal Scientific Education and Research Network [USERN], Tehran, Iran
  13. 13. Student Research Committee, Department of Physiology, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Current Cancer Drug Targets Published:2025


Abstract

Cancer is one of the leading causes of mortality and morbidity worldwide. It is characterized by unmanaged cell proliferation and growth, leading to tumour formation with the potential to metastasize to various organs of the human body. Currently, several common therapeutic approaches exist to treat malignancies, including chemotherapy, surgery, and radiotherapy, which can be used to prevent the progression of malignancies. However, these therapeutic approaches often face challenges due to their cytotoxic impacts and various side effects. Ergo is currently researching a new treatment that effectively reduces cancer progression with minimal side effects. Emerging evidence suggests that harnessing herbal sources, which are both accessible and safe, can be useful in improving various disorders, including cancer. Oridonin, a diterpenoid isolated from the traditional Chinese medicinal herb Rabdosia rubescens, has shown significant potential in cancer therapy. Moreover, numerous pharmacological and biological capacities have been attributed to this naturally active compound, such as anti-oxidative, anti-inflammatory, anti-bacterial, and anti-viral influences. This review summarizes the current knowledge on oridonin's mechanisms of action, particularly its effects on autophagy and apoptosis. While apoptosis is a well-established pathway for eliminating cancer cells through DNA fragmentation, autophagy plays a complex role, acting as both a cytoprotective and cell death mechanism depending on the context. We provide a comprehensive evaluation of the relevant studies, highlighting oridonin's potential in cancer control and identifying areas for further research. © 2024 Bentham Science Publishers.